Grady Grant III's Net Worth
-$7.19 Thousand
Who is Grady Grant III?
Grady Grant III does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Aptevo Therapeutics Inc..
SEC CIK
Grady Grant III's CIK is 0001679966
Past Insider Trading and Trends
2020 was Grady Grant III's most active year for acquiring shares with 3 total transactions. Grady Grant III's most active month to acquire stocks was the month of May. 2020 was Grady Grant III's most active year for disposing of shares, totalling 3 transactions. Grady Grant III's most active month to dispose stocks was the month of June. 2019 saw Grady Grant III paying a total of $7,970.00 for 35,000 shares, this is the most they've acquired in one year. In 2023 Grady Grant III cashed out on 3,868 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aptevo Therapeutics Inc. (APVO) Snapshot price: $0.16
Board Directors
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +272.80% | 3.57K |
—
|
—
| 4.88K |
Aug 9
| |||
Form 4
| +29.35% | 297 |
—
|
—
| 1.31K |
Jun 1 - Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
| +41.74% | 298 |
—
|
—
| 1.01K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 10K |
$0.80 | $7,970.00 | 10K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||